1
|
Kuyinu EL, Narayanan G, Nair LS and
Laurencin CT: Animal models of osteoarthritis: Classification,
update, and measurement of outcomes. J Orthop Surg. 11:192016.
View Article : Google Scholar
|
2
|
Bruyère O, Cooper C, Arden N, Branco J,
Brandi ML, Herrero-Beaumont G, Berenbaum F, Dennison E, Devogelaer
JP, Hochberg M, et al: Can we identify patients with high risk of
osteoarthritis progression who will respond to treatment? A focus
on epidemiology and phenotype of osteoarthritis. Drugs Aging.
32:179–187. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Arden N, Richette P, Cooper C, Bruyère O,
Abadie E, Branco J, Brandi ML, Berenbaum F, Clerc C, Dennison E, et
al: Can we identify patients with high risk of osteoarthritis
progression who will respond to treatment? A focus on biomarkers
and frailty. Drugs Aging. 32:525–535. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Moreau M, Pelletier JP, Lussier BV,
d'Anjou MA, Blond L, Pelletier JM, del Castillo JR and Troncy E: A
posteriori comparison of natural and surgical destabilization
models of canine osteoarthritis. BioMed Res Int. 33:851–855.
2013.
|
5
|
Heijink A, Gomoll AH, Madry H, Drobnič M,
Filardo G, Espregueira-Mendes J and Van Dijk CN: Biomechanical
considerations in the pathogenesis of osteoarthritis of the knee.
Knee Surg Sports Traumatol Arthrosc. 20:423–435. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Musumeci G, Castrogiovanni P, Trovato FM,
Weinberg AM, Al-Wasiyah MK, Alqahtani MH and Mobasheri A:
Biomarkers of chondrocyte apoptosis and autophagy in
osteoarthritis. Int J Mol Sci. 16:20560–20575. 2015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Batra J, Robinson J, Mehner C, Hockla A,
Miller E, Radisky DC and Radisky ES: PEGylation extends circulation
half-life while preserving in vitro and in vivo activity of tissue
inhibitor of metalloproteinases-1 (TIMP-1). PLoS One. 7:e500282012.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Foight GW and Keating AE: Locating
herpesvirus Bcl-2 homologs in the specificity landscape of
anti-apoptotic Bcl-2 proteins. J Mol Biol. 427:2468–2490. 2015.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Rother S, Samsonov SA, Moeller S,
Schnabelrauch M, Rademann J, Blaszkiewicz J, Köhling S,
Waltenberger J, Pisabarro MT, Scharnweber D, et al: Sulfate
hyaluronan alters endothelial cell activation in vitro by
controlling the biological activity of the angiogenic factors
vascular endothelial growth factor-A and tissue inhibitor of
metalloproteinase-3. ACS Appl Mater Interfaces. 9:9539–9550. 2017.
View Article : Google Scholar : PubMed/NCBI
|
10
|
McConnell S, Kolopack P and Davis AM: The
Western Ontario and McMaster Universities Osteoarthritis Index
(WOMAC): A review of its utility and measurement properties.
Arthritis Rheum. 45:453–461. 2001. View Article : Google Scholar : PubMed/NCBI
|
11
|
Valverde-Franco G, Lussier B, Hum D, Wu J,
Hamadjida A, Dancause N, Fahmi H, Kapoor M, Pelletier JP and
Martel-Pelletier J: Cartilage-specific deletion of ephrin-B2 in
mice results in early developmental defects and an
osteoarthritis-like phenotype during aging in vivo. Arthritis Res
Ther. 18:652016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lourenço S, Lucas R, Araújo F, Bogas M,
Santos RA and Barros H: Osteoarthritis medical labelling and
health-related quality of life in the general population. Health
Qual Life Outcomes. 12:1462014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kim C, Nevitt MC, Niu J, Clancy MM, Lane
NE, Link TM, Vlad S, Tolstykh I, Jungmann PM, Felson DT, et al:
Association of hip pain with radiographic evidence of hip
osteoarthritis: Diagnostic test study. BMJ. 351:h59832015.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Adamson A, Ghoreschi K, Rittler M, Chen Q,
Sun HW, Vahedi G, Kanno Y, Stetler-Stevenson WG, O'Shea JJ and
Laurence A: Tissue inhibitor of metalloproteinase 1 is
preferentially expressed in Th1 and Th17 T-helper cell subsets and
is a direct STAT target gene. PLoS One. 8:e593672013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Tency I, Verstraelen H, Kroes I,
Holtappels G, Verhasselt B, Vaneechoutte M, Verhelst R and
Temmerman M: Imbalances between matrix metalloproteinases (MMPs)
and tissue inhibitor of metalloproteinases (TIMPs) in maternal
serum during preterm labor. PLoS One. 7:e490422012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Hire JM, Evanson JL, Johnson PC, Zumbrun
SD, Guyton MK, McPherson JC III and Bojescul JA: Variance of matrix
metalloproteinase (MMP) and tissue inhibitor of metalloproteinase
(TIMP) concentrations in activated, concentrated platelets from
healthy male donors. J Orthop Surg. 9:292014. View Article : Google Scholar
|
17
|
Dhar A, Gardner J, Borgmann K, Wu L and
Ghorpade A: Novel role of TGF-β in differential astrocyte-TIMP-1
regulation: Implications for HIV-1-dementia and neuroinflammation.
J Neurosci Res. 83:1271–1280. 2006. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lee SY, Kwok SK, Son HJ, Ryu JG, Kim EK,
Oh HJ, Cho ML, Ju JH, Park SH and Kim HY: IL-17-mediated Bcl-2
expression regulates survival of fibroblast-like synoviocytes in
rheumatoid arthritis through STAT3 activation. Arthritis Res Ther.
15:R312013. View
Article : Google Scholar : PubMed/NCBI
|
19
|
Kernt M, Neubauer AS, Eibl KH, Wolf A,
Ulbig MW, Kampik A and Hirneiss C: Minocycline is cytoprotective in
human trabecular meshwork cells and optic nerve head astrocytes by
increasing expression of XIAP, survivin, and Bcl-2. Clin
Ophthalmol. 4:591–604. 2010. View Article : Google Scholar : PubMed/NCBI
|